Phase 2 Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 65 years old who have been admitted to hospital with a severe flare-up of ulcerative colitis (a condition causing inflammation of the large bowel)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with ulcerative colitis whose condition does not meet a specific set of medical criteria used to classify a severe flare-up (confirm with trial site)
- People who are already taking the medications Tofacitinib or Infliximab
- People who have latent (inactive but present) or active tuberculosis
- People diagnosed with Crohn's disease or a form of bowel inflammation that cannot be clearly classified as either Crohn's disease or ulcerative colitis
- People with a severely enlarged colon, where the main section of the large bowel measures 5.5 cm or more across and shows signs of swelling on an abdominal X-ray
- People who have a type of bowel infection called pseudomembranous colitis, or a bowel infection caused by a virus called CMV (cytomegalovirus), occurring at the same time as their current condition
- People who have a hole or tear in the bowel wall (intestinal perforation)
- People experiencing very heavy bleeding from the bowel that requires urgent surgery to remove part of the colon
- People who are pregnant or currently breastfeeding
- People who have been diagnosed with, or have a history of, blood clot conditions, or who have serious heart, lung, kidney, or liver problems
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vamsi Krishna Ankam, DrNB(gastroenterology), Asian Institute of Gastroenterology, Hyderabad
Phone: +91 9705904243
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical Remission Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.